Zurn Elkay Water Solutions Corporation (ZWS)

Jacques Butler, a director at Zurn Elkay Water Solutions Corp (ZWS), recently purchased 2,016 shares of the company's common stock for a total of $99,993. This insider transaction follows strong Q2 2026 performance by Zurn Elkay, which surpassed Wall Street expectations with higher earnings and revenue. Stifel has also maintained a Buy rating on ZWS, highlighting the company's strategic focus on niche markets.

Stifel reiterated a Buy rating and a $62 price target for Zurn Water Solutions (NYSE: ZWS), noting significant upside from its current trading price of $48.82. The company exhibits strong financial health with a Piotroski Score of 9 and impressive gross profit margins of 49%. Zurn is strategically targeting niche markets for growth, leveraging its technical capabilities and existing distribution channels, and recently reported strong Q2 2026 financial results, exceeding analyst expectations and raising its outlook.

Zurn Elkay Water Solutions Corp director Jacques Donavon Butler recently purchased 2,016 shares of the company's common stock for $99,993, bringing his total direct holdings to 37,487 shares. This insider purchase follows strong Q2 2026 performance for ZWS, which surpassed Wall Street expectations in earnings and revenue and boasts a Piotroski Score of 9. Stifel has also reiterated a Buy rating on the stock with a $62 price target, citing the company's strategic market initiatives.

Zurn Elkay Water Solutions (ZWS) has shown strong returns over five years, but its valuation is mixed. While a Discounted Cash Flow (DCF) model suggests the stock is undervalued by 10.9% relative to its intrinsic value, broader market multiples, particularly its P/E ratio of 31.0x, indicate it is overvalued compared to industry benchmarks. The discrepancy arises from the DCF model focusing on future cash flow generation versus market multiples reflecting high current earnings expectations.

Nine analysts have given Zurn Elkay Water Solutions Cor (NYSE:ZWS) a consensus "Moderate Buy" rating, with an average 12-month price target of $57.22. The company recently exceeded quarterly earnings expectations, reporting an adjusted EPS of $0.50 against a $0.47 consensus and revenue of $491 million, a 10.5% increase year-over-year. Institutional investors own a significant portion of the stock, approximately 83.33%.